363 related articles for article (PubMed ID: 33483337)
1. Persistence of mature dendritic cells, T
Bangert C; Rindler K; Krausgruber T; Alkon N; Thaler FM; Kurz H; Ayub T; Demirtas D; Fortelny N; Vorstandlechner V; Bauer WM; Quint T; Mildner M; Jonak C; Elbe-Bürger A; Griss J; Bock C; Brunner PM
Sci Immunol; 2021 Jan; 6(55):. PubMed ID: 33483337
[TBL] [Abstract][Full Text] [Related]
2. Early and Long-Term Effects of Dupilumab Treatment on Circulating T-Cell Functions in Patients with Moderate-to-Severe Atopic Dermatitis.
Bakker DS; van der Wal MM; Heeb LEM; Giovannone B; Asamoah M; Delemarre EM; Drylewicz J; Nierkens S; Boyman O; de Bruin-Weller MS; Thijs JL; van Wijk F
J Invest Dermatol; 2021 Aug; 141(8):1943-1953.e13. PubMed ID: 33610558
[TBL] [Abstract][Full Text] [Related]
3. Increased IL-26 Expression Promotes T Helper Type 17- and T Helper Type 2-Associated Cytokine Production by Keratinocytes in Atopic Dermatitis.
Kamijo H; Miyagaki T; Hayashi Y; Akatsuka T; Watanabe-Otobe S; Oka T; Shishido-Takahashi N; Suga H; Sugaya M; Sato S
J Invest Dermatol; 2020 Mar; 140(3):636-644.e2. PubMed ID: 31465744
[TBL] [Abstract][Full Text] [Related]
4. Single-cell transcriptome analysis of human skin identifies novel fibroblast subpopulation and enrichment of immune subsets in atopic dermatitis.
He H; Suryawanshi H; Morozov P; Gay-Mimbrera J; Del Duca E; Kim HJ; Kameyama N; Estrada Y; Der E; Krueger JG; Ruano J; Tuschl T; Guttman-Yassky E
J Allergy Clin Immunol; 2020 Jun; 145(6):1615-1628. PubMed ID: 32035984
[TBL] [Abstract][Full Text] [Related]
5. Dupilumab improves the molecular signature in skin of patients with moderate-to-severe atopic dermatitis.
Hamilton JD; Suárez-Fariñas M; Dhingra N; Cardinale I; Li X; Kostic A; Ming JE; Radin AR; Krueger JG; Graham N; Yancopoulos GD; Pirozzi G; Guttman-Yassky E
J Allergy Clin Immunol; 2014 Dec; 134(6):1293-1300. PubMed ID: 25482871
[TBL] [Abstract][Full Text] [Related]
6. Biologics for Atopic Dermatitis.
Boguniewicz M
Immunol Allergy Clin North Am; 2020 Nov; 40(4):593-607. PubMed ID: 33012322
[TBL] [Abstract][Full Text] [Related]
7. Mapping the immune cell landscape of severe atopic dermatitis by single-cell RNA-seq.
Jin SP; Lee K; Bang YJ; Jeon YH; Jung S; Choi SJ; Lee JS; Kim J; Guttman-Yassky E; Park CG; Kim HJ; Hong S; Lee DH
Allergy; 2024 Jun; 79(6):1584-1597. PubMed ID: 38817208
[TBL] [Abstract][Full Text] [Related]
8. Rosacea associated with dupilumab therapy.
Heibel HD; Hendricks AJ; Foshee JP; Shi VY
J Dermatolog Treat; 2021 Feb; 32(1):114-116. PubMed ID: 31132923
[No Abstract] [Full Text] [Related]
9. Pathogenesis of Atopic Dermatitis: Current Paradigm.
Furue M; Ulzii D; Vu YH; Tsuji G; Kido-Nakahara M; Nakahara T
Iran J Immunol; 2019 Jun; 16(2):97-107. PubMed ID: 31182684
[TBL] [Abstract][Full Text] [Related]
10. Single-cell RNA sequencing reveals 2D cytokine assay can model atopic dermatitis more accurately than immune-competent 3D setup.
Al B; Traidl S; Holzscheck N; Freimooser S; Mießner H; Reuter H; Dittrich-Breiholz O; Werfel T; Seidel JA
Exp Dermatol; 2024 May; 33(5):e15077. PubMed ID: 38711200
[TBL] [Abstract][Full Text] [Related]
11. Dupilumab progressively improves systemic and cutaneous abnormalities in patients with atopic dermatitis.
Guttman-Yassky E; Bissonnette R; Ungar B; Suárez-Fariñas M; Ardeleanu M; Esaki H; Suprun M; Estrada Y; Xu H; Peng X; Silverberg JI; Menter A; Krueger JG; Zhang R; Chaudhry U; Swanson B; Graham NMH; Pirozzi G; Yancopoulos GD; D Hamilton JD
J Allergy Clin Immunol; 2019 Jan; 143(1):155-172. PubMed ID: 30194992
[TBL] [Abstract][Full Text] [Related]
12. Efficacy of dupilumab for controlling severe atopic dermatitis with dominant-negative CARD11 variant.
Charvet E; Bourrat E; Hickman G; Donadieu J; Bellanné-Chantelot C; Jachiet M; Bouaziz JD; Bagot M; Cassius C
Clin Exp Dermatol; 2021 Oct; 46(7):1334-1335. PubMed ID: 33864281
[No Abstract] [Full Text] [Related]
13. Lesional dendritic cells in patients with chronic atopic dermatitis and psoriasis exhibit parallel ability to activate T-cell subsets.
Fujita H; Shemer A; Suárez-Fariñas M; Johnson-Huang LM; Tintle S; Cardinale I; Fuentes-Duculan J; Novitskaya I; Carucci JA; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2011 Sep; 128(3):574-82.e1-12. PubMed ID: 21704361
[TBL] [Abstract][Full Text] [Related]
14. Transcriptomic Analysis of Healthy and Atopic Dermatitis Samples Reveals the Role of IL-37 in Human Skin.
Zhou J; Gemperline DC; Turner MJ; Oldach J; Molignano J; Sims JT; Stayrook KR
Immunohorizons; 2021 Oct; 5(10):830-843. PubMed ID: 34702760
[TBL] [Abstract][Full Text] [Related]
15. Tape-Strip Proteomic Profiling of Atopic Dermatitis on Dupilumab Identifies Minimally Invasive Biomarkers.
He H; Olesen CM; Pavel AB; Clausen ML; Wu J; Estrada Y; Zhang N; Agner T; Guttman-Yassky E
Front Immunol; 2020; 11():1768. PubMed ID: 32849633
[TBL] [Abstract][Full Text] [Related]
16. Severe atopic dermatitis is characterized by selective expansion of circulating TH2/TC2 and TH22/TC22, but not TH17/TC17, cells within the skin-homing T-cell population.
Czarnowicki T; Gonzalez J; Shemer A; Malajian D; Xu H; Zheng X; Khattri S; Gilleaudeau P; Sullivan-Whalen M; Suárez-Fariñas M; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2015 Jul; 136(1):104-115.e7. PubMed ID: 25748064
[TBL] [Abstract][Full Text] [Related]
17. Transcriptomic Profiling of Tape-Strips From Moderate to Severe Atopic Dermatitis Patients Treated With Dupilumab.
Mikhaylov D; Del Duca E; Olesen CM; He H; Wu J; Ungar B; Estrada Y; Zhang N; Chowdhury M; Clausen ML; Krueger JG; Pavel AB; Agner T; Guttman-Yassky E
Dermatitis; 2021 Oct; 32(1S):S71-S80. PubMed ID: 34405829
[TBL] [Abstract][Full Text] [Related]
18. Intrinsic atopic dermatitis shows similar TH2 and higher TH17 immune activation compared with extrinsic atopic dermatitis.
Suárez-Fariñas M; Dhingra N; Gittler J; Shemer A; Cardinale I; de Guzman Strong C; Krueger JG; Guttman-Yassky E
J Allergy Clin Immunol; 2013 Aug; 132(2):361-70. PubMed ID: 23777851
[TBL] [Abstract][Full Text] [Related]
19. Dupilumab for the treatment of adolescents with atopic dermatitis.
Senner S; Seegräber M; Frey S; Kendziora B; Eicher L; Wollenberg A
Expert Rev Clin Immunol; 2020 Jul; 16(7):641-650. PubMed ID: 32720530
[TBL] [Abstract][Full Text] [Related]
20. Transglutaminase 3 Promotes Skin Inflammation in Atopic Dermatitis by Activating Monocyte-Derived Dendritic Cells via DC-SIGN.
Su H; Luo Y; Sun J; Liu X; Ling S; Xu B; Zhang Y; Liu J; Li W; Wang B; Yao X
J Invest Dermatol; 2020 Feb; 140(2):370-379.e8. PubMed ID: 31425706
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
